Company Introduction
Company Introduction
Driving Medical Innovation, Empowering Global Growth
| About Us
| About Us
China Pharmaceutical and Medical Device Enterprise Overseas Platform
China Pharmaceutical and Medical Device Enterprise Overseas Platform
Shinying Med Global was officially established in Shanghai, China in August 2023, with the core mission of driving medical innovation and empowering global growth. We specialize in providing professional support for Chinese pharmaceutical and medical device companies going global. We integrate three core advantages to help companies efficiently expand into global markets:
1. Professional Clinical Research Organization (CRO) services, laying a solid foundation for compliant market entry of pharmaceuticals and medical devices;
2. Globalized commercial channel solutions, opening up pathways for overseas market access and implementation;
3. Full-process global import and export services for pharmaceuticals and medical devices, along with a robust distribution network, ensuring efficient connection between production and sales.
Leveraging multi-dimensional synergistic efforts, we accelerate the product launch process for medical enterprises and broaden their global market footprint through a "dual-wheel drive + import/export implementation" model. With our professional capabilities and resource advantages, we aim to be a reliable strategic partner for Chinese pharmaceutical and medical device companies on their global journey, assisting them in achieving high-quality growth amidst the wave of the global pharmaceutical and healthcare industry.
As a strategic growth partner for medical enterprises, we have established a comprehensive service system covering "product compliance + commercial planning + import/export implementation," fully encompassing the pharmaceutical and medical device sectors in China and overseas. On the product side, we have built a comprehensive CRO service system that strictly adheres to international regulatory standards, laying a solid foundation for compliant market entry and helping companies overcome overseas market access barriers. On the commercial side, we have not only established a global sales network covering key markets such as China, Southeast Asia, the Middle East, Japan, South Korea, Brazil, and Australia, but we also deeply engage in the global import and export business of pharmaceuticals and medical devices. We possess complete import and export qualifications and professional operational capabilities, offering standardized full-process services from customs declaration, inspection, logistics, warehousing, to customs clearance and delivery, efficiently connecting global production and sales.
Shinying Med Global was officially established in Shanghai, China in August 2023, with the core mission of driving medical innovation and empowering global growth. We specialize in providing professional support for Chinese pharmaceutical and medical device companies going global. We integrate three core advantages to help companies efficiently expand into global markets:
1. Professional Clinical Research Organization (CRO) services, laying a solid foundation for compliant market entry of pharmaceuticals and medical devices;
2. Globalized commercial channel solutions, opening up pathways for overseas market access and implementation;
3. Full-process global import and export services for pharmaceuticals and medical devices, along with a robust distribution network, ensuring efficient connection between production and sales.
Leveraging multi-dimensional synergistic efforts, we accelerate the product launch process for medical enterprises and broaden their global market footprint through a "dual-wheel drive + import/export implementation" model. With our professional capabilities and resource advantages, we aim to be a reliable strategic partner for Chinese pharmaceutical and medical device companies on their global journey, assisting them in achieving high-quality growth amidst the wave of the global pharmaceutical and healthcare industry.
As a strategic growth partner for medical enterprises, we have established a comprehensive service system covering "product compliance + commercial planning + import/export implementation," fully encompassing the pharmaceutical and medical device sectors in China and overseas. On the product side, we have built a comprehensive CRO service system that strictly adheres to international regulatory standards, laying a solid foundation for compliant market entry and helping companies overcome overseas market access barriers. On the commercial side, we have not only established a global sales network covering key markets such as China, Southeast Asia, the Middle East, Japan, South Korea, Brazil, and Australia, but we also deeply engage in the global import and export business of pharmaceuticals and medical devices. We possess complete import and export qualifications and professional operational capabilities, offering standardized full-process services from customs declaration, inspection, logistics, warehousing, to customs clearance and delivery, efficiently connecting global production and sales.
Under the wave of upgrading and globalization in China's pharmaceutical industry, going global has become an important choice for enterprises to expand into the global market. As a core growth market for the ASEAN pharmaceutical and healthcare industry, Malaysia possesses a stable economic environment, expanding medical needs, and proactive industrial policies, making it a strategic hub for Chinese pharmaceutical and medical device companies to establish a presence in Southeast Asia.
Malaysia's pharmaceutical and healthcare industry is in a golden development period, with its total output value expected to exceed 35 billion Malaysian Ringgit (8.631 billion US dollars) by 2028, at a compound annual growth rate of 9.3%. Pharmaceuticals and medical devices are the two major growth engines. The pharmaceutical market revenue is projected to reach 1.702 billion US dollars in 2024, and the medical device market size will exceed 4.07 billion US dollars. The Malaysian pharmaceutical market has a high import dependency, with imported pharmaceuticals and medical devices accounting for over 50% and 90% of total sales, respectively, providing broad opportunities for high-quality Chinese pharmaceutical and medical device companies. The government continues to increase healthcare investment, promoting healthcare expenditure to exceed 5% of GDP, and encourages international cooperation through policies such as the "Bioeconomy Plan," creating a favorable environment for foreign enterprises.
Shinying Med, leveraging its localized service capabilities and deep resources, provides comprehensive overseas support for Chinese pharmaceutical and medical device companies, assisting them in progressing from "product export" to "brand establishment." It has built a full-cycle overseas service system of "channel empowerment + precise services + compliance assurance," which primarily covers three major segments.
Under the wave of upgrading and globalization in China's pharmaceutical industry, going global has become an important choice for enterprises to expand into the global market. As a core growth market for the ASEAN pharmaceutical and healthcare industry, Malaysia possesses a stable economic environment, expanding medical needs, and proactive industrial policies, making it a strategic hub for Chinese pharmaceutical and medical device companies to establish a presence in Southeast Asia.
Malaysia's pharmaceutical and healthcare industry is in a golden development period, with its total output value expected to exceed 35 billion Malaysian Ringgit (8.631 billion US dollars) by 2028, at a compound annual growth rate of 9.3%. Pharmaceuticals and medical devices are the two major growth engines. The pharmaceutical market revenue is projected to reach 1.702 billion US dollars in 2024, and the medical device market size will exceed 4.07 billion US dollars. The Malaysian pharmaceutical market has a high import dependency, with imported pharmaceuticals and medical devices accounting for over 50% and 90% of total sales, respectively, providing broad opportunities for high-quality Chinese pharmaceutical and medical device companies. The government continues to increase healthcare investment, promoting healthcare expenditure to exceed 5% of GDP, and encourages international cooperation through policies such as the "Bioeconomy Plan," creating a favorable environment for foreign enterprises.
Shinying Med, leveraging its localized service capabilities and deep resources, provides comprehensive overseas support for Chinese pharmaceutical and medical device companies, assisting them in progressing from "product export" to "brand establishment." It has built a full-cycle overseas service system of "channel empowerment + precise services + compliance assurance," which primarily covers three major segments.
Introduction to Overseas Business in Malaysia
Introduction to Overseas Business in Malaysia
Against the backdrop of the upgrading of China's pharmaceutical industry and the wave of globalization, expanding overseas has become an important choice for enterprises to develop global markets. Brazil, as the core growth market for the pharmaceutical and healthcare industry in Latin America, boasts a stable economic environment, continuously expanding medical needs, and proactive industrial policies, making it a strategic hub for Chinese pharmaceutical and medical device companies to establish a presence in Latin America.
Brazil's pharmaceutical and healthcare industry is in a golden development period. As the largest healthcare market in Latin America, its pharmaceutical market is valued at approximately 30 billion US dollars, and its medical device market is valued at approximately 10 billion US dollars, with growth rates ranking among the highest in the region. Pharmaceuticals and medical devices are the two major growth engines, with extremely high import dependence in the market, accounting for over 70% and 90% of total sales respectively, providing broad opportunities for high-quality Chinese pharmaceutical and medical device companies. The government continues to increase healthcare investment, improve healthcare system construction, and encourage international cooperation through policies such as localization support and simplified market access, creating a favorable environment for foreign enterprises.
Shinying Med has gradually initiated its market layout in Brazil. Relying on partners with many years of deep cultivation experience in the Brazilian healthcare market, and leveraging their profound industry resources and local insights, we are steadily advancing business implementation and achieving healthy growth in the Brazilian market, laying a solid foundation for subsequent in-depth expansion.
Against the backdrop of the upgrading of China's pharmaceutical industry and the wave of globalization, expanding overseas has become an important choice for enterprises to develop global markets. Brazil, as the core growth market for the pharmaceutical and healthcare industry in Latin America, boasts a stable economic environment, continuously expanding medical needs, and proactive industrial policies, making it a strategic hub for Chinese pharmaceutical and medical device companies to establish a presence in Latin America.
Brazil's pharmaceutical and healthcare industry is in a golden development period. As the largest healthcare market in Latin America, its pharmaceutical market is valued at approximately 30 billion US dollars, and its medical device market is valued at approximately 10 billion US dollars, with growth rates ranking among the highest in the region. Pharmaceuticals and medical devices are the two major growth engines, with extremely high import dependence in the market, accounting for over 70% and 90% of total sales respectively, providing broad opportunities for high-quality Chinese pharmaceutical and medical device companies. The government continues to increase healthcare investment, improve healthcare system construction, and encourage international cooperation through policies such as localization support and simplified market access, creating a favorable environment for foreign enterprises.
Shinying Med has gradually initiated its market layout in Brazil. Relying on partners with many years of deep cultivation experience in the Brazilian healthcare market, and leveraging their profound industry resources and local insights, we are steadily advancing business implementation and achieving healthy growth in the Brazilian market, laying a solid foundation for subsequent in-depth expansion.
Introduction to Brazil's Overseas Business
Introduction to Brazil's Overseas Business
Welcome to contact us
We always strive for ultimate professionalism and excellent quality, and sincerely look forward to win-win cooperation with you!
Shinying (Shanghai) Medical Technology Co., Ltd.
Shinying (Shanghai) Medical Technology Co., Ltd.
Contact Person: Ms. Zhou
E-mail: biz@medical-xy.com
ADD: 1st Floor, E4, Building 1, No. 389 Jinglian Road, Minhang District, Shanghai, China
Click to contact us
WeChat Official
Copyright © 2026, Shinying Med. All Rights Reserved.